Thrombolysis for Acute Minor Stroke: Outcome and Barriers to Management: Outcome

Cerebrovascular Diseases

Volumn 40, Issue 1-2, 2015, Pages 3-9

  Laurencin, Chloé ^a,f   Philippeau, Frédéric ^b,f   Blanc Lasserre, Karine ^c,f   Vallet, Anne Evelyne ^d,f   Cakmak, Serkan ^e,f   Mechtouff, Laura ^a,f   Cho, Tae Hee ^a,f   Ritzenthaler, Thomas ^a,f   Flocard, Elodie ^f   Bischoff, Magali ^f   El Khoury, Carlos ^f   Nighoghossian, Norbert ^a,f   Derex, Laurent ^a,f  

^a UNIVERSITÉ DE LYON   (France)

^b Centre Hospitalier de Bourg en Bresse   (France)

^c Valence Hospital   (France)

^d Department of Endocrinology   (France)

^e Resuscitation Unit   (France)

^f RESUVAL Stroke Network   (France)

Author keywords

Minor stroke; Stroke; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG SAFETY; EMERGENCY HEALTH SERVICE; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; STROKE UNIT; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DISABILITY; FRANCE; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; PATIENT TRANSPORT; PROCEDURES; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; DIAGNOSTIC IMAGING; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; FRANCE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT ADMISSION; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR; TRANSPORTATION OF PATIENTS; TREATMENT OUTCOME;

EID: 84929671912     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000381866     Document Type: Article

References (20)

1. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, Pagonabarraga J, Garcia-Bargo D, Mauri A, Marti-Vilalta JL: Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005; 64: 719-720
2. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM: Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015-1020
3. Breuer L, Blinzler C, Huttner HB, Kiphuth IC, Schwab S, Kohrmann M: Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'. Cerebrovasc Dis 2011; 32: 177-185
4. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24: 35-41
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
6. Greisenegger S, Seyfang L, Kiechl S, Lang W, Ferrari J; Austrian Stroke Unit Registry Collaborators: Thrombolysis in patients with mild stroke: results from the Austrian stroke unit registry. Stroke 2014; 45: 765-769
7. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group: Recombinant tissue plasminogen activator for minor strokes: the national institute of neurological disorders and stroke rt-PA stroke study experience. Ann Emerg Med 2005; 46: 243-252
8. Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Collaborative Group: Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the third international stroke trial. Stroke 2015; 46: 746-756
9. Derex L, Tomsick TA, Brott TG, Lewandowski CA, Frankel MR, Clark W, Starkman S, Spilker J, Udsten GJ, Khoury J, Grotta JC, Broderick JP; EMS Bridging Trial: Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. AJNR Am J Neuroradiol 2001; 22: 685-690
10. Lahoti S, Gokhale S, Caplan L, Michel P, Samson Y, Rosso C, Limaye K, Hinduja A, Singhal A, Ali S, Pettigrew LC, Kryscio R, Dedhia N, Hastak S, Liebeskind DS: Thrombolysis in ischemic stroke without arterial occlusion at presentation. Stroke 2014; 45: 2722-2727
11. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, Villablanca P, Vinuela F, Duckwiler G, Jahan R, Fredieu A, Suzuki S, Saver JL: Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 2006; 67: 980-984
12. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al; EXTEND-IA Investigators: Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009-1018
13. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al; MR CLEAN Investigators: A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 394
14. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS: Factors delaying hospital admission in acute stroke: the Copenhagen stroke study. Neurology 1996; 47: 383-387
15. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P: Factors influencing early admission in a French stroke unit. Stroke 2002; 33: 153-159
16. Chang KC, Tseng MC, Tan TY: Prehospital delay after acute stroke in Kaohsiung, Taiwan. Stroke 2004; 35: 700-704
17. Mazighi M, Derex L, Amarenco P: Prehospital stroke care: potential, pitfalls, and future. Curr Opin Neurol 2010; 23: 31-35
18. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS: Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344: 156-159
19. Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, Schwamm LH: Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke 2011; 42: 3110-3115
20. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, De Marchis GM, Kappeler L, Mono ML, Brekenfeld C, Schroth G, Mattle HP: What is a minor stroke? Stroke 2010; 41: 661-666